Concorde Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $755K | Sell |
3,088
-719
| -19% | -$167K | 0.37% | 60 |
|
|
2025
Q4 | $788K | Buy |
3,807
+13
| +0.3% | +$2.57K | 0.32% | 69 |
|
|
2025
Q3 | $705K | Buy |
+3,794
| New | +$650K | 0.29% | 72 |
|
|
2025
Q1 | $726K | Sell |
4,805
-197
| -4% | -$30.8K | 0.39% | 34 |
|
|
2024
Q4 | $723K | Sell |
5,002
-8
| -0.2% | -$1.24K | 0.38% | 41 |
|
|
2024
Q3 | $812K | Buy |
5,010
+124
| +3% | +$19.8K | 0.46% | 34 |
|
|
2024
Q2 | $714K | Sell |
4,886
-59
| -1% | -$8.78K | 0.44% | 33 |
|
|
2024
Q1 | $782K | Sell |
4,945
-177
| -3% | -$28.2K | 0.54% | 29 |
|
|
2023
Q4 | $756K | Buy |
5,122
+389
| +8% | +$59.6K | 0.51% | 31 |
|
|
2023
Q3 | $737K | Buy |
4,733
+2,275
| +93% | +$375K | 0.66% | 31 |
|
|
2023
Q2 | $394K | Buy |
2,458
+184
| +8% | +$29.7K | 0.36% | 59 |
|
|
2023
Q1 | $336K | Sell |
2,274
-189
| -8% | -$30.5K | 0.4% | 49 |
|
|
2022
Q4 | $407K | Sell |
2,463
-814
| -25% | -$141K | 0.36% | 67 |
|
|
2022
Q3 | $449K | Buy |
3,277
+202
| +7% | +$34.2K | 0.5% | 63 |
|
|
2022
Q2 | $451K | Buy |
3,075
+605
| +24% | +$108K | 0.68% | 42 |
|
|
2022
Q1 | $411K | Buy |
2,470
+106
| +4% | +$18K | 0.27% | 87 |
|
|
2021
Q4 | $396K | Sell |
2,364
-460
| -16% | -$75.3K | 0.24% | 114 |
|
|
2021
Q3 | $457K | Sell |
2,824
-20
| -0.7% | -$3.41K | 0.26% | 122 |
|
|
2021
Q2 | $462K | Sell |
2,844
-132
| -4% | -$21.9K | 0.26% | 99 |
|
|
2021
Q1 | $480K | Buy |
2,976
+10
| +0.3% | +$1.62K | 0.28% | 92 |
|
|
2020
Q4 | $442K | Sell |
2,966
-443
| -13% | -$65.4K | 0.25% | 82 |
|
|
2020
Q3 | $466K | Buy |
3,409
+1,608
| +89% | +$238K | 0.27% | 97 |
|
|
2020
Q2 | $216K | Sell |
1,801
-2,904
| -62% | -$423K | 0.18% | 112 |
|
|
2020
Q1 | $617K | Sell |
4,705
-317
| -6% | -$45K | 0.63% | 39 |
|
|
2019
Q4 | $730K | Sell |
5,022
-332
| -6% | -$45K | 0.51% | 56 |
|
|
2019
Q3 | $693K | Sell |
5,354
-1,528
| -22% | -$201K | 0.53% | 55 |
|
|
2019
Q2 | $960K | Sell |
6,882
-552
| -7% | -$76.4K | 0.56% | 55 |
|
|
2019
Q1 | $1.04M | Buy |
7,434
+174
| +2% | +$23.3K | 0.67% | 43 |
|
|
2018
Q4 | $937K | Sell |
7,260
-54
| -0.7% | -$7.53K | 0.79% | 34 |
|
|
2018
Q3 | $1.01M | Sell |
7,314
-854
| -10% | -$113K | 0.99% | 28 |
|
|
2018
Q2 | $992K | Sell |
8,168
-1,508
| -16% | -$188K | 1.13% | 22 |
|
|
2018
Q1 | $1.25M | Buy |
9,676
+379
| +4% | +$51.2K | 1.53% | 15 |
|
|
2017
Q4 | $1.3M | Sell |
9,297
-3,994
| -30% | -$556K | 1.64% | 14 |
|
|
2017
Q3 | $1.73M | Buy |
13,291
+3,534
| +36% | +$468K | 1.5% | 8 |
|
|
2017
Q2 | $1.29M | Buy |
9,757
+693
| +8% | +$88.4K | 1.74% | 11 |
|
|
2017
Q1 | $1.13M | Buy |
9,064
+4,071
| +82% | +$486K | 1.86% | 14 |
|
|
2016
Q4 | $575K | Sell |
4,993
-901
| -15% | -$104K | 1.03% | 32 |
|
|
2016
Q3 | $692K | Buy |
5,894
+462
| +9% | +$56K | 0.87% | 34 |
|
|
2016
Q2 | $658K | Buy |
5,432
+1,621
| +43% | +$184K | 0.65% | 33 |
|
|
2016
Q1 | $412K | Buy |
3,811
+973
| +34% | +$101K | 0.47% | 54 |
|
|
2015
Q4 | $292K | Sell |
2,838
-925
| -25% | -$93K | 0.33% | 76 |
|
|
2015
Q3 | $353K | Sell |
3,763
-1,406
| -27% | -$136K | 0.6% | 58 |
|
|
2015
Q2 | $514K | Sell |
5,169
-1,959
| -27% | -$196K | 0.65% | 39 |
|
|
2015
Q1 | $717K | Sell |
7,128
-459
| -6% | -$46.7K | 0.82% | 28 |
|
|
2014
Q4 | $584K | Buy |
+7,587
| New | +$800K | 0.73% | 34 |
|
Other funds holding JNJ
VCM
VPM
Concorde Asset Management's JNJ Position: Q1 2026 in Review
Concorde Asset Management reduced its Johnson & Johnson (JNJ) stake by 19% in Q1 2026, selling an estimated $167K and leaving 3,088 shares worth $755K. The position accounts for 0.37% of the portfolio, ranked #60.
Concorde Asset Management first reported a position in JNJ in Q4 2014 and has held it in 45 quarters since. The position peaked at $1.73M in Q3 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Concorde Asset Management held 3,088 shares of Johnson & Johnson worth $755K as of Q1 2026.
- Concorde Asset Management sold 719 Johnson & Johnson shares in Q1 2026, an estimated $167K.
- Johnson & Johnson made up 0.37% of Concorde Asset Management's portfolio in Q1 2026, its #60 holding.
- Concorde Asset Management first reported a position in Johnson & Johnson in Q4 2014 and has held it in 45 quarters since.
- Concorde Asset Management's Johnson & Johnson position peaked at $1.73M in Q3 2017.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Concorde Asset Management's 13F filing for Q1 2026, filed 1 Jun 2026.